Trials / Unknown
UnknownNCT03686020
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The study is designed to measure serum and salivary CYFRA21-1 levels using enzyme linked immunosorbent assay (ELISA) in patients with oral malignancy, oral potentially malignant lesions, and control subjects to evaluate the potential of CYFRA21-1 as a diagnostic marker for malignant transformation in potentially malignant oral mucosal lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Enzyme Linked Immunosorbent assay (ELISA) | measure serum and salivary CYFRA21-1 levels in all included participants using Enzyme Linked Immunosorbent assay (ELISA) |
Timeline
- Start date
- 2018-10-23
- Primary completion
- 2019-10-01
- Completion
- 2019-12-01
- First posted
- 2018-09-26
- Last updated
- 2019-07-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03686020. Inclusion in this directory is not an endorsement.